| pubmed-article:19903791 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C1524059 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C1458155 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0963057 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0728747 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:19903791 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:19903791 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:19903791 | pubmed:dateCreated | 2009-11-13 | lld:pubmed |
| pubmed-article:19903791 | pubmed:abstractText | Resistance to anti-HER2 monoclonal antibody trastuzumab is a relevant issue in breast cancer patients. Among the mechanisms implicated in trastuzumab resistance, increasing evidence supports a role of tumor microenvironment. We previously found that a novel toll-like receptor 9 agonist, referred to as immune modulatory oligonucleotide (IMO) and currently under clinical investigation, acts through epidermal growth factor receptor (EGFR) and shows direct antiangiogenic effects by cooperating with anti-EGFR or anti-VEGF drugs, thus interfering with cancer cells and microenvironment. | lld:pubmed |
| pubmed-article:19903791 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19903791 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19903791 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19903791 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19903791 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:AgrawalSudhir... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:TortoraGiampa... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:KandimallaEka... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:CaputoRosaR | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:GarbiCorradoC | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:BiancoRoberto... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:DamianoVincen... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:RacioppiLuigi... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:GelardiTeresa... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:GarofaloSonia... | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:RosaRobertaR | lld:pubmed |
| pubmed-article:19903791 | pubmed:author | pubmed-author:MerolaGerardi... | lld:pubmed |
| pubmed-article:19903791 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19903791 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19903791 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:19903791 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19903791 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19903791 | pubmed:pagination | 6921-30 | lld:pubmed |
| pubmed-article:19903791 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:meshHeading | pubmed-meshheading:19903791... | lld:pubmed |
| pubmed-article:19903791 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19903791 | pubmed:articleTitle | A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action. | lld:pubmed |
| pubmed-article:19903791 | pubmed:affiliation | Departments of Endocrinologia ed Oncologia Molecolare e Clinica, and Biologia e Patologia Cellulare e Molecolare L. Califano, Università di Napoli Federico II, Napoli, Italy. | lld:pubmed |
| pubmed-article:19903791 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:54106 | entrezgene:pubmed | pubmed-article:19903791 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19903791 | lld:entrezgene |
